Current Report Filing (8-k)
June 03 2021 - 4:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
|
|
May 28, 2021
|
Retractable
Technologies, Inc.
(Exact name of registrant as specified in
its charter)
Texas
|
|
001-16465
|
|
75-2599762
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS
Employer
|
of incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
511 Lobo Lane, Little Elm, Texas
|
|
75068-5295
|
(Address of principal executive offices)
|
|
(Zip
Code)
|
Registrant's telephone number, including area code
|
|
(972) 294-1010
|
None
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
RVP
|
NYSE American
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company ¨
|
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 1.01
|
Entry into a Material Definitive Agreement
|
Effective May 28,
2021, the Company entered into an amendment to the delivery order from the U.S. Department of Health and Human Services which was
awarded May 1, 2020. The amendment changes the period of performance end date from May 2021 to March 2022 and
reallocates the products ordered to increase shipments of 1mL low dead-space safety syringes.
Attached as Exhibit 99.1 is a press release dated June 3, 2021 announcing the amendment.
On June 1, 2021, the
Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing its receipt of a notice
regarding the extension of a government contract.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
DATE: June 3, 2021
|
RETRACTABLE TECHNOLOGIES, INC.
|
|
(Registrant)
|
|
BY:
|
/s/ JOHN W. FORT III
|
|
|
JOHN W. FORT III
|
|
|
VICE PRESIDENT, CHIEF FINANCIAL OFFICER, AND CHIEF ACCOUNTING OFFICER
|
Retractable Technologies (AMEX:RVP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Retractable Technologies (AMEX:RVP)
Historical Stock Chart
From Apr 2023 to Apr 2024